CONNECTING THE DOTS – ELEVATOR PITCH SESSION ON KNOWLEDGE FOR GROWTH 2024
Connecting the dots
Immunity for health is organising an Elevator Pitch session ‘Connecting the dots’ on Knowledge for Growth, the annual business conference of flanders.bio, attracting each year several decision makers, investors, renowned researchers, policymakers and competence providers from all fields of the Life Sciences sector.
One of the main goals of Immunity for health is to bridge the gap between academic research and corporate development by creating awareness about early stage, pre-competitive novel technologies available in the Immunity for health network.
The Immunity for health Elevator Pitch session offers a unique opportunity to connect academic researchers, entrepreneurs, TTO’s, business managers, scientific advisors and investors within the field of Vaccines and Immunotherapy.
Four talented researchers and budding entrepreneurs will present their innovative project to an audience of potential partners and will benefit from the extensive scientific and business experience of the expert panel.
Panel of experts:
Mr Benjamin Damien,
Founder & Chief Executive Officer, Sagitta Biotech
Mrs Vanessa Vankerckhoven,
Founder & Chief Executive Officer, Idevax
Mr Viggo Van Tendeloo,
Director, Early Innovation Partnering, Benelux, J&J Innovation
Mrs Carla Snoeck,
Senior New Ventures Manager, VIB
Mr Stijn Lagaert,
European and Belgian Patent Attorney, Gevers
Programme
14:00 Welcome – Dr. ir. Sven Arnouts, Chairman of Immunity for health
14:05 BAXERNA: Next-Generation Bacterial mRNA Vaccines
Lyudmila Kovalchuke, Project Manager, VIB-UGent.
14:18 High-sensitive immunopeptidomics uncovers actionable antigens paving the way for optimized vaccine development
Pieter-Paul Strybol, Business Developer, ImmuneSpec
14:31 Resuscitating cell therapy for solid tumors: engineered CAR NK cells to overcome the immunosuppressive microenvironment Jorrit De Waele, Post-doctoral researcher in Tumor immunology, University of Antwerp
14:44 Novel Treatment of Urothelial Cancer of the Bladder in Dogs
Annelies Bogaerts, Chief Development Officer, Benno Therapeutics
14:57 Closing Word – Dr. ir. Sven Arnouts
Interested in pitching?
The call for abstracts is closed.
Are you a researcher from a university or start-up company with a brilliant idea or innovative technology in the field of vaccine development or immunotherapy with a valuable application to improve human or animal health, do not miss this opportunity.
What’s in it for you?
- Showcase your innovative project to an audience of potential partners
- Receive constructive feedback and advice from a panel of experts, consisting of investors, innovation managers & business development executives
- Connect with potential partners who could finance and support your project
- Meet the Life Science community present at Knowledge for Growth
- A chance to win a financial award from a professional jury.
*Submit your abstract before April 22th, 2024
Practical information
- Thursday May 16th 2024
- Session: 2 – 3 PM (Galapagos room)
- Flanders Meeting & Convention Center Antwerp, Koningin Astridplein 26, Antwerp, Belgium
More information: Knowledge for Growth 2024
For any further information, please contact:
Immunity for health Project Manager
Fran Van Heuverswyn
Tel.: +32 (0) 11 28 69 04
Our members & strategic partners
Organizations with expertise in immunology, oncology, vaccinology and infectious diseases, are invited to join Immunity for Health. Together, we build a strong network, fostering innovation in diagnostics, medical devices, immunotherapeutics, and vaccines for humans and animals and across the entire value chain—from R&D to manufacturing, supply, marketing, and beyond. Join us to make impact!
